Please login to the form below

Not currently logged in
Email:
Password:

Unlimited Group appoints group managing director

Michael Richards joins the group from VCCP

Michael RichardsUnlimited Group has appointed Michael Richards as group managing director, a role that will see him “capitalise on new opportunities”.

The appointment comes following the recent announcement of the group’s restructure and rebrand around its seven core disciplines.

Tim Bonnet, president of the Unlimited Group, said: “I am really excited about Michael’s appointment.

“With our simplified and honed client offer we are ready for a sustained period of accelerated client growth, which Michael has an enviable track record in delivering.”

Richards joins the group from VCCP, where he held the role of international managing director.

He said: “Unlimited Group is a gem, with some great agency brands.

“I’m very excited to be working with such an impressive team, being wingman to the existing management and looking forward to lots of collective success and fun delivering great outcomes for our clients as we bring our new proposition ‘the impact of art and sciences’ to life.

Richards will head the group’s partners’ board and will report into the group Chairman Ian Ferguson.

8th May 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics